These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impact of Primary Tumor Size on Prognosis in Patients With Metastatic Renal Cell Carcinoma Receiving Cytoreductive Nephrectomy: A Population Study of a Chinese Center and the US SEER Database. Jiang W; Shou J; Shi H; Wen L; Zhang H; Zheng S; Li C; Ma J Technol Cancer Res Treat; 2021; 20():15330338211019507. PubMed ID: 34032149 [TBL] [Abstract][Full Text] [Related]
3. Does postoperative radiation therapy impact survival in non-metastatic sarcomatoid renal cell carcinoma? A SEER-based study. Eminaga O; Akbarov I; Wille S; Engelmann U Int Urol Nephrol; 2015 Oct; 47(10):1653-63. PubMed ID: 26329746 [TBL] [Abstract][Full Text] [Related]
4. Comparison of oncologic outcomes between sarcomatoid and clear cell renal cell carcinoma. Trudeau V; Larcher A; Sun M; Boehm K; Dell'Oglio P; Sosa J; Tian Z; Fossati N; Briganti A; Shariat SF; Karakiewicz PI World J Urol; 2016 Oct; 34(10):1429-36. PubMed ID: 26902877 [TBL] [Abstract][Full Text] [Related]
7. Impact of Perioperative Infection on Cancer Specific Survival after Nephrectomy for Renal Cell Carcinoma. Tallman JE; Pearce SM; Kuchta K; Helfand BT; Eggener SE J Urol; 2017 Nov; 198(5):1027-1032. PubMed ID: 28551443 [TBL] [Abstract][Full Text] [Related]
8. Is there a role for partial nephrectomy in patients with metastatic renal cell carcinoma? Hellenthal NJ; Mansour AM; Hayn MH; Schwaab T Urol Oncol; 2013 Jan; 31(1):36-41. PubMed ID: 21396834 [TBL] [Abstract][Full Text] [Related]
9. Clinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation: Natural history and outcomes after surgical resection with curative intent. Merrill MM; Wood CG; Tannir NM; Slack RS; Babaian KN; Jonasch E; Pagliaro LC; Compton Z; Tamboli P; Sircar K; Pisters LL; Matin SF; Karam JA Urol Oncol; 2015 Apr; 33(4):166.e21-9. PubMed ID: 25700975 [TBL] [Abstract][Full Text] [Related]
10. Nodal involvement at nephrectomy is associated with worse survival: a stage-for-stage and grade-for-grade analysis. Sun M; Bianchi M; Hansen J; Abdollah F; Trinh QD; Lughezzani G; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI Int J Urol; 2013 Apr; 20(4):372-80. PubMed ID: 23039208 [TBL] [Abstract][Full Text] [Related]
11. A Population Study to Identify Candidates for Cytoreductive Nephrectomy in Patients with Metastatic Sarcomatoid Renal Cell Carcinoma from the Surveillance, Epidemiology, and End Results (SEER) Database. Ji B; Li D; Fu S; Zhang Z; Yang T; Wu Y; Zuo Y; Xu Z; Yu N Med Sci Monit; 2020 Jun; 26():e921297. PubMed ID: 32516796 [TBL] [Abstract][Full Text] [Related]
12. The Role of Cytoreductive Nephrectomy for Sarcomatoid Renal Cell Carcinoma: A 29-Year Institutional Experience. Silagy AW; Mano R; Blum KA; DiNatale RG; Marcon J; Tickoo SK; Reznik E; Coleman JA; Russo P; Hakimi AA Urology; 2020 Feb; 136():169-175. PubMed ID: 31726184 [TBL] [Abstract][Full Text] [Related]
13. Localised non-metastatic sarcomatoid renal cell carcinoma: a 31-year externally verified study. Blum KA; Silagy AW; Knezevic A; Weng S; Wang A; Mano R; Marcon J; DiNatale RG; Sanchez A; Tickoo S; Gupta S; Motzer R; Haas NB; Kim SE; Uzzo RG; Coleman JA; Hakimi AA; Russo P BJU Int; 2024 Feb; 133(2):169-178. PubMed ID: 37589200 [TBL] [Abstract][Full Text] [Related]
14. Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma. Shuch B; Bratslavsky G; Shih J; Vourganti S; Finley D; Castor B; Treat E; Linehan WM; Pantuck AJ; Said JW; Belldegrun AS BJU Int; 2012 Jun; 109(11):1600-6. PubMed ID: 22221668 [TBL] [Abstract][Full Text] [Related]
15. Population-based analysis of factors associated with survival in patients undergoing cytoreductive nephrectomy in the targeted therapy era. Culp SH; Karam JA; Wood CG Urol Oncol; 2014 Jul; 32(5):561-8. PubMed ID: 24709415 [TBL] [Abstract][Full Text] [Related]
16. Treatments, Outcomes, and Validity of Prognostic Scores in Patients With Sarcomatoid Renal Cell Carcinoma: A 20-Year Single-Institution Experience. Korenbaum C; Pierard L; Thiéry A; Story F; Lindner V; Lang H; Kurtz JE; Barthélémy P Clin Genitourin Cancer; 2018 Jun; 16(3):e577-e586. PubMed ID: 29395949 [TBL] [Abstract][Full Text] [Related]
17. The predictive role of preoperative and postoperative neutrophil-lymphocyte ratio in sarcomatoid renal cell carcinoma. Mano R; Flynn J; Blum KA; Silagy AW; DiNatale RG; Marcon J; Wang A; Sanchez A; Coleman JA; Russo P; Ostrovnaya I; Hakimi AA Urol Oncol; 2019 Dec; 37(12):916-923. PubMed ID: 31590969 [TBL] [Abstract][Full Text] [Related]
18. Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study. Capitanio U; Zini L; Perrotte P; Shariat SF; Jeldres C; Arjane P; Pharand D; Widmer H; Péloquin F; Montorsi F; Patard JJ; Karakiewicz PI Urology; 2008 Nov; 72(5):1090-5. PubMed ID: 18799207 [TBL] [Abstract][Full Text] [Related]
19. Renal cell carcinoma and brain metastasis: Questioning the dogma of role for cytoreductive nephrectomy. Daugherty M; Daugherty E; Jacob J; Shapiro O; Mollapour M; Bratslavsky G Urol Oncol; 2019 Mar; 37(3):182.e9-182.e15. PubMed ID: 30528396 [TBL] [Abstract][Full Text] [Related]
20. The Natural History of Renal-Cell Carcinoma with Sarcomatoid Differentiation, a Stage-by-Stage Analysis. Tully KH; Berg S; Paciotti M; Janisch F; Reese SW; Noldus J; Shariat SF; Choueiri T; Müller G; McGregor B; Chang SL; Trinh QD; Mossanen M Clin Genitourin Cancer; 2023 Feb; 21(1):63-68. PubMed ID: 36517393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]